S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

Sotera Health Stock Forecast, Price & News

+1.17 (+4.59 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $26.68
50-Day Range
MA: $26.78
52-Week Range
Now: $26.68
Volume852,607 shs
Average Volume717,673 shs
Market Capitalization$7.40 billion
P/E RatioN/A
Dividend YieldN/A
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the United States and internationally. Its sterilization services include gamma and electron beam irradiation, and EO processing; and lab services comprise analytical chemistry, medical device, and pharmaceutical lab testing, as well as microbiology testing. The company also provides Co-60 and gamma irradiators, which are principal components to the gamma sterilization process. Its microbiology testing services help customers to identify and measure the potential risks of microbes to a product and ensure that the quality of the products is maintained; and advisory services help customers in navigating the regulatory requirements applicable throughout the product lifecycle. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is based in Broadview Heights, Ohio.
Sotera Health logo

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Market Cap$7.40 billion
Next Earnings Date3/9/2021 (Confirmed)
OptionableNot Optionable


Overall MarketRank

2.08 out of 5 stars

Medical Sector

29th out of 1,972 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

1st out of 25 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
+1.17 (+4.59 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SHC News and Ratings via Email

Sign-up to receive the latest news and ratings for SHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Sotera Health (NYSE:SHC) Frequently Asked Questions

Is Sotera Health a buy right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sotera Health in the last year. There are currently 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Sotera Health stock.
View analyst ratings for Sotera Health
or view top-rated stocks.

What stocks does MarketBeat like better than Sotera Health?

Wall Street analysts have given Sotera Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sotera Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Sotera Health's next earnings date?

Sotera Health is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for Sotera Health

What guidance has Sotera Health issued on next quarter's earnings?

Sotera Health updated its fourth quarter 2020 Pre-Market earnings guidance on Monday, January, 11th. The company provided EPS guidance of for the period. The company issued revenue guidance of $216-216 million, compared to the consensus revenue estimate of $206.91 million.

What price target have analysts set for SHC?

10 brokers have issued 12-month target prices for Sotera Health's shares. Their forecasts range from $31.00 to $35.00. On average, they expect Sotera Health's stock price to reach $32.55 in the next twelve months. This suggests a possible upside of 22.0% from the stock's current price.
View analysts' price targets for Sotera Health
or view top-rated stocks among Wall Street analysts.

Who are Sotera Health's key executives?

Sotera Health's management team includes the following people:
  • Mr. Michael B. Petras Jr., Chairman & CEO (Age 54, Pay $2.47M)
  • Mr. Scott J. Leffler, CFO & Treasurer (Age 46, Pay $2.24M)
  • Mr. Matthew J. Klaben Esq., Sr. VP, Gen. Counsel & Sec. (Age 51, Pay $892.38k)
  • Mr. Kevin Theriault, Sr. VP of Operations
  • Mr. Robert G. Hauzie, Chief Information Officer
  • Mr. Kurt M. Roth, Sr. VP of Corp. Devel. & Strategy
  • Ms. Kristin A. Gibbs, Chief Marketing Officer
  • Ms. Sally R. Turner, Chief HR Officer
  • Mr. Eric W. Beers, Sr. VP - Engineering
  • Ms. Kathleen A. Hoffman, Sr. VP of Global Environmental, Health & Safety

Who are some of Sotera Health's key competitors?

When did Sotera Health IPO?

(SHC) raised $1 billion in an initial public offering on Friday, November 20th 2020. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup and RBC Capital Markets acted as the underwriters for the IPO and BNP Paribas, Keybanc Capital Markets, Citizens Capital Markets and ING were co-managers.

What is Sotera Health's stock symbol?

Sotera Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "SHC."

When does the company's lock-up period expire?

Sotera Health's lock-up period expires on Wednesday, May 19th. Sotera Health had issued 46,600,000 shares in its IPO on November 20th. The total size of the offering was $1,071,800,000 based on an initial share price of $23.00. After the expiration of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Who are Sotera Health's major shareholders?

Sotera Health's stock is owned by many different institutional and retail investors. Top institutional investors include Warburg Pincus LLC (42.87%), BlackRock Inc. (2.64%), Lazard Asset Management LLC (1.32%), Janus Henderson Group PLC (1.26%), Wells Fargo & Company MN (0.51%) and Nuveen Asset Management LLC (0.42%).

Which institutional investors are buying Sotera Health stock?

SHC stock was bought by a variety of institutional investors in the last quarter, including Warburg Pincus LLC, BlackRock Inc., Lazard Asset Management LLC, Janus Henderson Group PLC, Wells Fargo & Company MN, Nuveen Asset Management LLC, Kornitzer Capital Management Inc. KS, and Select Equity Group L.P..

How do I buy shares of Sotera Health?

Shares of SHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sotera Health's stock price today?

One share of SHC stock can currently be purchased for approximately $26.68.

How much money does Sotera Health make?

Sotera Health has a market capitalization of $7.40 billion.

How many employees does Sotera Health have?

Sotera Health employs 2,900 workers across the globe.

What is Sotera Health's official website?

The official website for Sotera Health is www.soterahealth.com.

Where are Sotera Health's headquarters?

Sotera Health is headquartered at 9100 SOUTH HILLS BLVD SUITE 300, BROADVIEW HEIGHTS OH, 44147.

How can I contact Sotera Health?

Sotera Health's mailing address is 9100 SOUTH HILLS BLVD SUITE 300, BROADVIEW HEIGHTS OH, 44147. The company can be reached via phone at 440-262-1410 or via email at [email protected]

This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.